Literature DB >> 15255036

Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the Prospective P2C2 HIV Multicenter Study.

A R Perez-Atayde1, D I Kearney, J T Bricker, S D Colan, K A Easley, S Kaplan, W W Lai, S E Lipshultz, D S Moodie, G Sopko, T J Starc.   

Abstract

Arteriopathy in human immunodeficiency virus (HIV)-infected patients is being increasingly recognized, especially in children. However, few studies have histologically evaluated the coronary arteries in HIV-infected children, and none have systematically assessed the aorta and pulmonary arteries. The coronary arteries, thoracic aorta, and the main and branch pulmonary arteries from the postmortem hearts of 14 HIV-infected children were systematically reviewed for vasculopathic lesions and compared with 14 age-matched controls. Findings from the HIV-infected children were compared with clinical, laboratory, and other postmortem findings. Coronary arteriopathy, seen in seven (50%) of the HIV-infected children, was primarily calcific, and it was associated with decreased CD3 and CD4 peripheral blood counts. Large vessel arteriopathy, seen in 9 (64%) of the 14 HIV-infected children, was primarily centered on the vasa vasorum and consisted mainly of medial hypertrophy and chronic inflammation. Large vessel lesions were associated with increased left ventricular mass z-scores (P = 0.02), and 78% of patients with large vessel arteriopathy had postmortem cardiomegaly. Coronary and large vessel arteriopathies are common in pediatric HIV-infection and have different clinicopathologic features suggesting different pathogenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15255036     DOI: 10.1007/s10024-003-1001-9

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  10 in total

1.  Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Authors:  Tracie L Miller; Gabriel Somarriba; E John Orav; Armando J Mendez; Daniela Neri; Natasha Schaefer; Lourdes Forster; Ronald Goldberg; Gwendolyn B Scott; Steven E Lipshultz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

Review 2.  Cardiovascular complications in children with HIV infection.

Authors:  Amy Sims; Colleen Hadigan
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

3.  Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

Authors:  T I Miller; W Borkowsky; L A DiMeglio; L Dooley; M E Geffner; R Hazra; E J McFarland; A J Mendez; K Patel; G K Siberry; R B Van Dyke; C J Worrell; D L Jacobson; William Shearer; Norma Cooper; Lynette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Doyle Patton; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Ram Yogev; Kathleen Malee; Scott Hunter; Eric Cagwin; Andrew Wiznia; Marlene Burey; Molly Nozyce; Janet Chen; Elizabeth Gobs; Mitzie Grant; Katherine Knapp; Kim Allison; Patricia Garvie; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Cheryl Borne; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Emily Barr; Carrie Chambers; Douglas Watson; Nicole Messenger; Rose Belanger; Arry Dieudonne; Linda Bettica; Susan Adubato; Gwendolyn Scott; Lisa Himic; Elizabeth Willen
Journal:  HIV Med       Date:  2011-12-04       Impact factor: 3.180

4.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

Review 5.  Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future.

Authors:  Bibhuti B Das
Journal:  Paediatr Drugs       Date:  2022-05-02       Impact factor: 3.022

Review 6.  Heart Failure with Preserved Ejection Fraction in Children.

Authors:  Bibhuti Das; Shriprasad Deshpande; Jyothsna Akam-Venkata; Divya Shakti; William Moskowitz; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2022-08-17       Impact factor: 1.838

7.  Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.

Authors:  Steven E Lipshultz; Paige L Williams; James D Wilkinson; Erin C Leister; Russell B Van Dyke; William T Shearer; Kenneth C Rich; Rohan Hazra; Jonathan R Kaltman; Denise L Jacobson; Laurie B Dooley; Gwendolyn B Scott; Nicole Rabideau; Steven D Colan
Journal:  JAMA Pediatr       Date:  2013-06       Impact factor: 16.193

8.  Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.

Authors:  Steven E Lipshultz; James D Wilkinson; Bruce Thompson; Irene Cheng; David A Briston; William T Shearer; E John Orav; Joslyn A Westphal; Tracie L Miller; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

9.  Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia.

Authors:  Rudolph L Gleason; Alexander W Caulk; Daniel Seifu; Ivana Parker; Brani Vidakovic; Helena Getenet; Getachew Assefa; Wondwossen Amogne
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk.

Authors:  Keon-Young Park; Gande Li; Manu O Platt
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.